Digital Health Startups

Anipos operates an information platform for the pet healthcare and pet insurance industries, offering a pet insurance claims app for owners, an OCR service that digitizes paper insurance claims, and ANIPOS Cloud, a full-package core system for pet insurance operators. It serves pet owners, veterinary clinics, research institutions, pharmaceutical companies, and insurance providers in Japan.

2 investors

Kaiju Company develops technology and AI products for mental health self-care, including U2plus, a Japanese self-care community for people with depression with around 40,000 members, and mimo AI, an AI-based self-counseling tool. The company focuses on bridging the gap between self-care and medical treatment through technology and design in Japan.

2 investors

Cardio Intelligence develops AI-based electrocardiogram analysis software as medical device programs, including its SmartRobin AI long-term ECG analysis series and SmartPAFin software for detecting signs of paroxysmal atrial fibrillation. The company is a licensed medical device manufacturer and distributor based in Tokyo, Japan.

2 investors

Shaperon builds AI software to help companies in regulated industries handle complex, industry-specific compliance and legal requirements. Its compliance AI aims to speed up work and raise compliance standards for sectors where high-stakes, expert-driven judgment is required.

2 investors

Digireha (株式会社デジリハ) develops digital rehabilitation tools for people with disabilities, working under the mission of building a future not constrained by disability. The company frames disability through the "social model," treating the difficulties disabled people face as originating in society rather than the individual.

2 investors

Plusmedi Corp. develops patient-facing smartphone apps ("wellcne" and "MyHospital") and operates a personal health record (PHR) business. The company serves patients and healthcare providers in Japan.

2 investors

Japanese healthcare startup (Mental Health Technologies, Inc.) that runs businesses in mental health solutions, medical workforce shift services, medical career support, and digital marketing, centered on connecting companies with physicians to address employees' physical and mental health. It serves corporate employers seeking to improve workforce well-being and occupational health.

2 investors

Rehasaku provides cloud-based rehabilitation and physical therapy management systems for medical institutions and treatment clinics in Japan. The platform includes exercise therapy management, guidance support tools, AI-powered posture analysis, appointment scheduling, and web marketing support.

2 investors

Synyi (Shanghai Synyi Intelligent Information Technology), founded in 2016, develops AI, large language models, and big-data technologies for healthcare, offering more than 20 AI medical solutions covering clinical diagnosis and quality control, hospital operations management, and clinical research. It serves hospitals, medical alliances, healthcare companies, and health regulators, primarily in China, and is headquartered in Shanghai.

2 investors

Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices. Founded in 2004 and publicly listed (300347.SZ / 3347.HK), it provides services including clinical monitoring, regulatory affairs, data management, and site management.

2 investors

GroovyX runs a global medical tourism business, helping Korean hospitals attract international patients through a system that combines its platform, data, and operations. It provides hospital marketing, digital advertising, data-driven growth strategy, and B2B partnerships focused on the Korean aesthetic/cosmetic medicine market.

1 investor

LabGenomics is a molecular diagnostics and healthcare company providing genetic testing for individuals from pregnant women to newborns, along with personalized microbiome analysis of oral and vaginal flora. It develops disease diagnosis methods and personalized health management services.

1 investor

MEKICS (Medical Equipment of Korea Intensive Care System) develops and manufactures critical-care medical devices, including patient monitors, mechanical ventilators, home CPAP machines, and combined respiratory therapy equipment. The South Korean company focuses on respiratory and intensive-care devices for the medical market and aims to expand internationally.

1 investor

BrainOK (브레인오케이) is a mobile self-assessment app that adapts over 50 hospital-grade neuropsychological tests (such as TMT, Stroop Test, Digit Span, and Symbol Coding) to measure attention, memory, language, visuospatial, and executive function and to detect early signs of dementia and mild cognitive impairment. It serves individuals doing regular self-checks, at-risk groups, and medical, welfare, and cognitive-health research settings.

1 investor

VUNO develops AI-based medical device software for hospitals, providing solutions that analyze patient data such as ECG readings, chest X-rays, and fundus images. The South Korean company operates as an AI healthcare provider with medical diagnostic products and consumer health services.

1 investor

Slowave develops lightweight wireless patch-type EEG devices and brain-signal analysis algorithms to support clinicians' diagnosis of neuropsychiatric conditions such as sleep disorders, delirium, and ADHD. The company builds data-driven neuro-healthcare tools intended for use in clinical settings.

1 investor

C&R Research is a contract research organization providing end-to-end clinical trial services, including regulatory and non-regulatory trials as well as multinational studies. It has conducted around 1,800 clinical trials, including 79 global multinational trials, over 29 years.

1 investor

Apollon develops needle-free continuous glucose monitors for diabetes care using Raman spectroscopy-based optical sensing. Its wearable device, MOGLU, targets non-invasive glucose measurement and is being developed by teams in Boston and Seoul.

1 investor

Zerorder develops AI-based medical technology to address infant torticollis, aiming to provide effective and affordable treatment for affected babies. The company brings together software engineers, designers, and other specialists at the intersection of healthcare and technology.

1 investor

GeneCker develops CRISPR/Cas9-based liquid biopsy diagnostics for early cancer detection, analyzing low-frequency circulating tumor DNA (ctDNA) mutations in blood. The company serves the in vitro diagnostics market with ultra-sensitive genomic testing for precision cancer diagnosis.

1 investor

KAVILAB develops AI-based surgical planning software and patient-specific medical devices, extracting 3D skeletal models from CT scans to automatically design optimal surgical strategies and custom implants. Used in university hospital clinical settings, its technology is validated in fracture fixation surgery and expanding into joint replacement surgery planning.

1 investor

TL Genomics develops in vitro diagnostic medical products and healthcare testing services, focusing on bone marrow transplant testing, chromosome analysis for disease risk and fertility assessment, and related medical services.

1 investor

ANDBAM sells a shampoo and conditioner combo formulated to address hair loss and scalp health through active ingredients like DHT blockers and growth stimulants. The products target consumers seeking thicker, fuller hair through a direct-to-consumer model.

1 investor

1 True Health provides a care delivery and health management program for older adults living at home, supporting care plan compliance, medication management, and daily task coordination. It also serves the caregivers and organizations that help care for aging adults.

1 investor